Position in JNJ
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$97,257,053
+$26,458,424 QoQ
Shares Held
397,877
+16.3% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Andra AP-fonden holds $451,805,560 across 10 Drug Manufacturers - General names. JNJ ranks #2 (21.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
127,233 | $117,025,096 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
397,877 | $97,257,053 | |
| 3 | ABBV |
AbbVie Inc.
|
283,811 | $61,726,054 | |
| 4 | AZN |
Astrazeneca PLC
|
236,302 | $46,603,480 | |
| 5 | MRK |
Merck & Co., Inc.
|
364,485 | $43,843,900 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
222,601 | $31,023,901 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
332,662 | $20,175,950 | |
| 8 | AMGN |
Amgen Inc
|
50,366 | $17,721,277 |
All Filings in JNJ
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $97,257,053 | 397,877 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $70,798,629 | 342,105 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $37,380,672 | 201,600 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $31,878,925 | 208,700 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $19,005,264 | 114,600 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $21,664,076 | 149,800 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $63,219,606 | 390,100 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $67,408,992 | 461,200 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $29,897,910 | 189,000 | Shares | Sole | 2024-05-13 | |
| 2023-06-30 | $8,441,520 | 51,000 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $9,129,500 | 58,900 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,454,630 | 42,200 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $9,948,624 | 60,900 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,964,174 | 67,400 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $15,430,514 | 90,200 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $16,844,450 | 104,300 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $15,732,670 | 95,500 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $17,158,140 | 104,400 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $16,446,210 | 104,500 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $7,652,432 | 51,400 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $7,706,524 | 54,800 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $6,412,257 | 48,900 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||